Main description:

Cardiac catheterization and coronary angiography remain key tools in the management of patients with coronary heart disease. Although this is the most frequently used method of coronary revascularization, general training in cardiology rarely offers more than the opportunity to assist a more senior operator to perform angioplasty procedures.

This textbook, covering key procedures and fully revised and updated to include the latest trials, technology, and new techniques, is essential reading. The Oxford Textbook of Interventional Cardiology, 2nd edition spans the whole spectrum of interventional cardiology procedures, including a novel section on the future of interventional cardiology, and multiple new chapters covering special devices in percutaneous coronary intervention. Written by an expert team of international
authors, this book offers guidance on all aspects of interventional cardiology according the European curriculum, and covers the evidence-based guidelines for a comprehensive view of the field.

Contents:

Background and basics
1: Robert Henderson, Richard Varcoe: The epidemiology and pathophysiology of coronary artery disease
2: Toby Rogers, Kenneth Kent, and Augusto D. Pichard: The history of interventional cardiology
3: Peter F. Ludman: Risk assessment and analysis of outcomes
4: David H. Roberts: Vascular access: femoral versus radial
5: Gurbir Bhatia, James Nolan: Radiation and percutaneous coronary intervention
6: Rod Stables: The 'golden rules' of percutaneous coronary intervention
7: Kevin O'Gallagher, Jonathan Byrne, and Philip MacCarthy: Routine management after percutaneous coronary intervention
8: Ayman Al-Saleh and Sanjit Jolly: Trial design and interpretation: statistics in PCI
Percutaneous coronary intervention-related imaging
9: David Adlam, Annette Maznyczka, and Bernard Prendergast: Angiography: indications and limitations
10: Olivier Muller, Stephane Fournier, Bernard De Bruyne: Coronary physiology in clinical practice
11: Hiromasa Otake, Yasuhiro Honda, and Peter J. Fitzgerald: The role of intravascular ultrasound in percutaneous coronary intervention
12: Ravinay Bhindi and Keith M. Channon: Optical Coherence Tomography in Percutaneous Coronary Intervention
13: A. Coenen, L.E. Swart, R.P.J. Budde, and K. Nieman: Coronary computed tomography for the interventionalist
14: Theodoros D. Karamitsos and Stefan Neubauer: Cardiovascular magnetic resonance
Percutaneous coronary intervention by clinical syndrome
15: Vasim Farooq and Patrick W. Serruys: Stable coronary artery disease: medical therapy versus percutaneous coronary intervention versus surgery
16: Bashir Alaour, Michael Mahmoudi and Nick Curzen: Percutaneous coronary intervention in non-ST elevation acute coronary syndrome
17: Zulfiquar Adam and Mark A. de Belder: Primary percutaneous coronary intervention for ST elevation myocardial infarction
18: Divaka Perera and Natalia Briceno: Percutaneous coronary intervention in patients with impaired left ventricular function
Percutaneous coronary intervention by lesion and patient subsets
19: Yves Louvard, Philippe Garot, Thomas Hovasse, Bernard Chevalier, and Thierry Lefevre: Coronary bifurcation stenting: state of the art
20: Michael Mahmoudi, Nick Curzen, Christine Hughes, Bruno Farah, and Jean Fajadet: Percutaneous coronary intervention for unprotected and protected left main stem disease
21: Colm G. Hanratty, James C. Spratt, Simon J. Walsh: Chronic total occlusions
22: George Kassimis and Adrian P. Banning: Revascularisation in patients with diabetes mellitus
23: Marko Noc and Peter Radsel: Out of Hospital Arrest: Role of PCI
Adjunctive drug therapies in percutaneous coronary intervention
24: Vikram Khanna, Tony Gershlick and Nick Curzen: Current status of oralantiplatelet therapies
25: Tim Lockie: Current status of GP IIb/IIIa inhibitors
26: Stefanie Schupke, Steffen Massberg, and Adnan Kastrati: The role of bivalirudin in percutaneous coronary intervention
27: Simon J. Corbett and Nick Curzen: Optimal medical therapy in percutaneous coronary intervention patients: statins and ACE inhibitors as disease-modifying agents
28: Mikhail S. Dzeshka, Richard A. Brown, and Gregory Y.H. Lip: New Oral Anti-Coagulants (NOACs) and other Adjunctive Therapies
Complications of percutaneous coronary intervention
29: Peter A. McCullough: Contrast-induced acute kidney injury
30: Jaya Chandrasekhar, Adriano Caixeta, Philippe Genereux, George Dangas, and Roxana Mehran: In-stent restenosis in the drug-eluting stent era
31: Nikesh Malik, Amerjeet Banning, and Tony Gershlick: Stent thrombosis
32: Adam de Belder: Stent loss and retrieval
33: Mark Gunning and Chee Wah Khoo: Coronary artery perforation
Special devices in percutaneous coronary intervention
34: Adam de Belder, Martyn Thomas, and Emanuele Barbato: Rotational atherectomy
35: Peter O'Kane and Simon Redwood: Laser
36: Giovanni Luigi De Maria and Adrian P. Banning: Saphenous Vein Graft PCI, Distal Protection and no-reflow
37: Adam J. Brown and Nick E. J. West: Bioresorbable Vascular Scaffolds
38: Corrado Tamburino, Claudia Ina Tamburino and Sebastiano Imme: Access Sites and the TAVI Procedure
39: Mohamed Abdel-Wahab and John Jose: Selection of TAVI Prostheses
40: Muhammed Zeeshan Khawaja and Simon Redwood: Co-existent Coronary Artery Disease in Patients Undergoing TAVI: When and When Not to Treat
41: Michael Bellamy and Christopher Baker: Transcatheter Mitral Valve Repair
42: Ricardo Boix Garibo, Mohsin Uzzaman, Michael Ghosh-Dastidar, and Vinayak Bapat: Transcatheter Mitral Valve Replacement
Other Non-coronary percutaneous interventions
43: Patrick A. Calvert, Bushra S. Rana, Roland Hilling-Smith, and David Hildick-Smith: Percutaneous device closure of atrial septal defect and patent foramen ovale
44: Alec Vahanian, Dominique Himbert, Eric Brochet, Gregory Ducrocq, and Bernard Iung: Mitral balloon valvuloplasty
45: Charles Knight, Saidi Mohiddin, and Constantinos O'Mahony: Alcohol septal ablation for obstructive hypertrophic cardiomyopathy
46: Iqbal Malik and Mohamed Hamady: Carotid artery stenting
47: Tim Betts: Left Atrial Appendage Occlusion
The Future
48: Kenneth Chan, Manish Saxena, and Melvin D. Lobo: Novel Therapies for Hypertension
49: Giora Weisz: Robotic PCI
50: Fizzah Choudry and Anthony Mathur: Stem Cell Therapy and Delivery